Multimodal data drives biomarker innovation
We spoke with Gilead experts to learn how the company uses multimodal data to achieve early successes in translational biomarker research and discovery.
Dec 06, 2022
Life Sciences
Webinar
Ryan FukushimaChief Operating Officer, Tempus
Scott Patterson, PhDVice President of Biomarker Sciences, Gilead Sciences, Inc.
Shahed Iqbal, PhDSenior Director and Head of Molecular Epidemiology, Biomarker Sciences, Gilead Sciences, Inc.


